Thomas F. DeLaney, M.D. is a graduate of Harvard College and Harvard Medical School. He trained in Radiation Oncology at the Massachusetts General Hospital (MGH) and spent 6 years as Senior Investigator at the National Cancer Institute. Since 1992, he has been on staff at MGH where he is the Medical Director of the Burr Proton Therapy Center and Co-Director of the Center for Sarcoma and Connective Tissue Oncology. He is Associate Professor of Radiation Oncology at Harvard Medical School.
Dr. DeLaney has made important contributions to the treatment of soft tissue and bone sarcomas as well as the use of charged particle (proton) radiation therapy. His bibliography lists 65 original reports as well as 84 reviews and book chapters. He is on the editorial boards of Annals of Surgical Oncology, Journal of Surgical Oncology, Journal of Clinical Oncology.and UpToDate in Oncology.
My major research efforts have been in the development and testing of innovative cancer treatment approaches in clinical trials. Primary areas of interest have been soft tissue and bone sarcomas in adults and adolescents, as well as the application of advanced radiation oncology technologies including charged particle radiation with protons and brachytherapy (i.e. placement of radiation sources in close proximity to the tumor to deliver high doses of radiation to the tumor while sparing nearby normal tissue).
The MGH Cancer Center has added pencil-beam scanning to the radiation therapy modalities offered at the hospital’s Burr Proton Therapy Center.